| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nephrology Dialysis Transplantation, Vol 13, Issue 11 2853-2860, Copyright © 1998 by Oxford University Press
M Kooistra, J Vos, H Koomans and P Vos
Background: More frequent dialysis has been claimed to
improve clinical outcome and quality of life. Methods:
Clinical status was optimized in 13 haemodialysis patients during a run-in
period of 2 months with three dialysis sessions a week. Thereafter, daily
home haemodialysis (DHHD, 6 sessions per week) was initiated. The total
weekly dialysis dose (Kt/V) was kept constant.
Results: Weekly Kt/V was 3.2±0.13
(M±SEM) before, and 3.2±0.15 after 6 months of DHHD
(NS), time averaged concentration of urea (TACu) was 21.2±1.6
mmol/l and 20.1±0.9 mmol/l (NS). Urea reduction was
0.56±0.05 before DHHD, and 0.41±0.06 during DHHD
(P<0.0001). Serum K remained unchanged, but significantly less
exchange resins were used (P<0.02). Also, the dose of
phosphate-binding agents could be decreased. Values for Na, K, Cl,
bicarbonate, Ca, PTH, albumin, and Hb remained unchanged. Iron deficiency
developed in some patients. Twenty-four-hour blood pressure monitoring
showed a decrease of systolic blood pressure (141.1±17.2 mmHg
before, and 130.9±19.2 mmHg during DHHD, P<0.001).
Diastolic blood pressure remained constant (82.8±7.2 and
76.9±10.1 mmHg, NS). Mean arterial pressure decreased from
102.2±9.5 to 94.9±1.4 mmHg (P<0.02). Blood
pressure decreased mainly in previously hypertensive patients. Mean target
weight increased 0.8 kg. The amount of antihypertensive drugs used
decreased from 1.88±0.35 to 0.75±0.17
(P<0.005, n=7). Dialysis sessions were much more stable, also in
patients with cardiac insufficiency. Quality of life questionnaires (Rand
36, Nottingham Health Profile, Uraemic Symptoms Profile) showed a
significant improvement of physical condition and fewer uraemic symptoms.
Conclusion: DHHD compared to conventional
thrice-weekly haemodialysis with similar weekly Kt/V results in an improved
haemodynamic control and quality of life, but has lesser impact on
metabolic regulation. Key words: daily home
haemodialysis; hypertension; quality of life
ORIGINAL ARTICLES
Daily home haemodialysis in the Netherlands; effects on metabolic control, heamodynamics, and quality of life
Stichting Thuisdialyse Midden-West Nederland (Foundation of Home Dialysis Mid-West Netherlands) and Department of Nephrology, University Hospital Utrecht, Utrecht, The Netherlands; Corresponding author at: Stichting Thuisdialyse Midden-West Nederland, Brennerbann 130, 3524 BN Utrecht, Nederland
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. A. Cafazzo, K. Leonard, A. C. Easty, P. G. Rossos, and C. T. Chan Patient-Perceived Barriers to the Adoption of Nocturnal Home Hemodialysis Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 784 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fong, J. M. Bargman, and C. T. Chan Cross-Sectional Comparison of Quality of Life and Illness Intrusiveness in Patients Who Are Treated with Nocturnal Home Hemodialysis versus Peritoneal Dialysis Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1195 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. McFarlane, A. Pierratos, A. M. Bayoumi, and D. A. Redelmeier Estimating Preference Scores in Conventional and Home Nocturnal Hemodialysis Patients Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 477 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Vos, O. Zilch, A. Jennekens-Schinkel, M. Salden, J. Nuyen, M. P. Kooistra M, A. C. van Huffelen, and M. M. Sitskoorn Effect of short daily home haemodialysis on quality of life, cognitive functioning and the electroencephalogram Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2529 - 2535. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Lindsay, P. A. Heidenheim, G. Nesrallah, A. X. Garg, R. Suri, and on behalf of the Daily Hemodialysis Study Group Lo Minutes to Recovery after a Hemodialysis Session: A Simple Health-Related Quality of Life Question That Is Reliable, Valid, and Sensitive to Change Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 952 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton CHAPTER 5: Frequent and Sustained Hemodialysis J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S24 - S27. [Full Text] [PDF] |
||||
![]() |
R. S. Suri, G. E. Nesrallah, R. Mainra, A. X. Garg, R. M. Lindsay, T. Greene, and J. T. Daugirdas Daily Hemodialysis: A Systematic Review Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 33 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Sung, S.-C. Kuo, H.-R. Guo, S.-F. Chuang, S.-Y. Lee, and J.-J. Huang Decreased Salivary Flow Rate as a Dipsogenic Factor in Hemodialysis Patients: Evidence from an Observational Study and a Pilocarpine Clinical Trial J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3418 - 3429. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Ayus, M. R. Mizani, S. G. Achinger, R. Thadhani, A. S. Go, and S. Lee Effects of Short Daily versus Conventional Hemodialysis on Left Ventricular Hypertrophy and Inflammatory Markers: A Prospective, Controlled Study J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2778 - 2788. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nanovic Electrolytes and Fluid Management in Hemodialysis and Peritoneal Dialysis Nutr Clin Pract, April 1, 2005; 20(2): 192 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Bots, H. S. Brand, E. C. I. Veerman, J. C. Korevaar, M. Valentijn-Benz, P. D. Bezemer, R. M. Valentijn, P. F. Vos, J. A. Bijlsma, P. M. ter Wee, et al. Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis Nephrol. Dial. Transplant., March 1, 2005; 20(3): 578 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. C. Grooteman and M. J. Nube Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter? Nephrol. Dial. Transplant., December 1, 2004; 19(12): 2965 - 2970. [Full Text] [PDF] |
||||
![]() |
M. P. Kooistra Frequent prolonged home haemodialysis: three old concepts, one modern solution Nephrol. Dial. Transplant., January 1, 2003; 18(1): 16 - 18. [Full Text] [PDF] |
||||
![]() |
Z. J. Twardowski PHD(R): the technological solution for daily haemodialysis? Nephrol. Dial. Transplant., January 1, 2003; 18(1): 19 - 23. [Full Text] [PDF] |
||||
![]() |
A. Floridi, F. Antolini, F. Galli, R. M. Fagugli, E. Floridi, and U. Buoncristiani Daily haemodialysis improves indices of protein glycation Nephrol. Dial. Transplant., May 1, 2002; 17(5): 871 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Drueke Foreword: Extraskeletal calcifications in patients with chronic renal failure Nephrol. Dial. Transplant., February 1, 2002; 17(2): 330 - 331. [Full Text] [PDF] |
||||
![]() |
Z. J. Twardowski Daily dialysis: is this a reasonable option for the new millennium? Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1321 - 1324. [Full Text] [PDF] |
||||
![]() |
M. Schomig, A. Eisenhardt, and E. Ritz Controversy on optimal blood pressure on haemodialysis: normotensive blood pressure values are essential for survival Nephrol. Dial. Transplant., March 1, 2001; 16(3): 469 - 474. [Full Text] [PDF] |
||||
![]() |
I. Ledebo, N. Lameire, B. Charra, F. Locatelli, M. Kooistra, M. Kessler, and C. Jacobs Improving the outcome of dialysis--opinion vs scientific evidence Nephrol. Dial. Transplant., September 1, 2000; 15(9): 1310 - 1316. [Full Text] [PDF] |
||||
![]() |
T. Ring, M. P. Merkus, and R. T. Krediet Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of dialysis (NECOSAD) Nephrol. Dial. Transplant., February 1, 2000; 15(2): 280 - 281. [Full Text] [PDF] |
||||
![]() |
A. Pierratos Nocturnal home haemodialysis: an update on a 5-year experience Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2835 - 2840. [Full Text] [PDF] |
||||



